Mogamulizumab-kpkc Intravenous and Pioglitazone and metformin
Determining the interaction of Mogamulizumab-kpkc Intravenous and Pioglitazone and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Pioglitazone and Metformin Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Pioglitazone and Metformin Tablets
- Mogamulizumab-kpkc Intravenous-Pioglitazone Hydrochloride
- Mogamulizumab-kpkc Intravenous-Pioglitazone Tablets
- Mogamulizumab-kpkc Intravenous-Piperacillin
- Mogamulizumab-kpkc Intravenous-Piperacillin and tazobactam
- Pioglitazone and metformin-Molindone
- Pioglitazone and metformin-Mometasone (Oral Inhalation)
- Pioglitazone and metformin-Mometasone and Formoterol
- Pioglitazone and metformin-Mometasone and formoterol Inhalation
- Pioglitazone and metformin-Mometasone Cream
- Pioglitazone and metformin-Mometasone Furoate